REPLICATEPriority claimed from 06/12/2021; Application No. : 97157972 ;United States of America (Class 5)
#5474002
Application Number:5474002
Status:
Unknown
Class:5
Applicant: Replicate Bioscience, Inc.
Filing Date:Fri, 03 Jun 2022
Get a free email alert the moment this application's status changes.
Trademark Information
| Trademark | REPLICATEPriority claimed from 06/12/2021; Application No. : 97157972 ;United States of America |
| Trademark Type | Wordmark |
| Class | 5 |
| Application Number | 5474002 |
| Nature/Scope of business | harmaceutical and biologic preparations; Biological components being a component in vaccines; Therapeutic agents and immunotherapies for the treatment of cancer, autoimmune diseases, inflammatory diseases, and infectious diseases; Biological compound for medical use, namely, self-replicating RNAs delivered into patient cells for creating therapeutic proteins; Therapeutic agents for generating or evading protective immune response |
| Publication | In Journal No. 2169 |
| Status | Unknown |
| Applicant: | Replicate Bioscience, Inc. |
| Applicant Address | 10210 Campus Point Drive, Suite 150, San Diego, California 92121, United States of America A Delaware Corporation |
| Jurisdiction | DELHI |
| Agent | LALL & SETHI |
| Agent Address | D-17, South Extension Part II, New Delhi 110049, India |
Frequently Asked Questions
Who is the owner of trademark REPLICATEPriority claimed from 06/12/2021; Application No. : 97157972 ;United States of America? ▾
The trademark application number 5474002 is owned by Replicate Bioscience, Inc..
Which class does trademark REPLICATEPriority claimed from 06/12/2021; Application No. : 97157972 ;United States of America belong to? ▾
Trademark application number 5474002 is filed under Class 5, which relates to the specified goods and services.
Who is the trademark agent for application 5474002? ▾
The trademark agent associated with application number 5474002 is LALL & SETHI.
Was trademark REPLICATEPriority claimed from 06/12/2021; Application No. : 97157972 ;United States of America published in the journal? ▾
Yes, trademark application number 5474002 was published in Journal No. 2169.
What is trademark REPLICATEPriority claimed from 06/12/2021; Application No. : 97157972 ;United States of America? ▾
Trademark application number 5474002 relates to "harmaceutical and biologic preparations; Biological components being a component in vaccines; Therapeutic agents and immunotherapies for the treatment of cancer, autoimmune diseases, inflammatory diseases, and infectious diseases; Biological compound for medical use, namely, self-replicating RNAs delivered into patient cells for creating therapeutic proteins; Therapeutic agents for generating or evading protective immune response".
File Trademark at Just ₹1,499 + Govt Fees
Get your trademark registered with expert guidance. Limited time offer!
File NowExpert Consultation
Quick Processing
100% Support
Free Report
Get Detailed Trademark Report
Comprehensive analysis of your trademark search delivered to your phone
What you'll get:
- Complete trademark analysis
- Conflict assessment
- Registration guidance
15,000+Trademarks Filed
98%Success Rate
Govt Authorized
ISO Certified